-
Canadian Agency Recommends Ruzurgi Be Reimbursed with Conditions
A Canadian agency has recommended that Ruzurgi be reimbursed for the treatment of LEMS in patients 6 and older, under certain conditions. Read the full story here.
Do you agree with this recommendation?
Sorry, there were no replies found.
Log in to reply.